Return On Assets of Hepion Pharmaceuticals, Inc. from 30 Jun 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Hepion Pharmaceuticals, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2014 to 30 Sep 2025.
  • Hepion Pharmaceuticals, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -227%, a 9.3% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2024 was -193%, a 27% decline from 2023.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2023 was -152%, a 178% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2022 was -55%, a 91% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -227% -19% -9.3% 01 Jul 2025 30 Sep 2025
Q2 2025 -336% -162% -93% 01 Apr 2025 30 Jun 2025
Q1 2025 -373% -211% -131% 01 Jan 2025 31 Mar 2025
Q4 2024 -193% -42% -27% 01 Oct 2024 31 Dec 2024
Q3 2024 -207% -103% -99% 01 Jul 2024 30 Sep 2024
Q2 2024 -174% -95% -120% 01 Apr 2024 30 Jun 2024
Q1 2024 -161% -87% -118% 01 Jan 2024 31 Mar 2024
Q4 2023 -152% -97% -178% 01 Oct 2023 31 Dec 2023
Q3 2023 -104% -53% -104% 01 Jul 2023 30 Sep 2023
Q2 2023 -79% -33% -70% 01 Apr 2023 30 Jun 2023
Q1 2023 -74% -43% -137% 01 Jan 2023 31 Mar 2023
Q4 2022 -55% -26% -91% 01 Oct 2022 31 Dec 2022
Q3 2022 -51% -23% -85% 01 Jul 2022 30 Sep 2022
Q2 2022 -46% -15% -46% 01 Apr 2022 30 Jun 2022
Q1 2022 -31% +10% +24% 01 Jan 2022 31 Mar 2022
Q4 2021 -29% +41% +59% 01 Oct 2021 31 Dec 2021
Q3 2021 -28% +52% +65% 01 Jul 2021 30 Sep 2021
Q2 2021 -32% +27% +46% 01 Apr 2021 30 Jun 2021
Q1 2021 -41% +1% +2.6% 01 Jan 2021 31 Mar 2021
Q4 2020 -70% -31% -81% 01 Oct 2020 31 Dec 2020
Q3 2020 -80% -31% -63% 01 Jul 2020 30 Sep 2020
Q2 2020 -59% -17% -39% 01 Apr 2020 30 Jun 2020
Q1 2020 -42% +49% +54% 01 Jan 2020 31 Mar 2020
Q4 2019 -39% +56% +59% 01 Oct 2019 31 Dec 2019
Q3 2019 -49% 01 Jul 2019 30 Sep 2019
Q2 2019 -43% 01 Apr 2019 30 Jun 2019
Q1 2019 -91% 01 Jan 2019 31 Mar 2019
Q4 2018 -95% 01 Oct 2018 31 Dec 2018
Q3 2017 -105% +68% +39% 01 Jul 2017 30 Sep 2017
Q2 2017 -108% +96% +47% 01 Apr 2017 30 Jun 2017
Q1 2017 -178% +90% +34% 01 Jan 2017 31 Mar 2017
Q4 2016 -165% +84% +34% 01 Oct 2016 31 Dec 2016
Q3 2016 -173% +93% +35% 01 Jul 2016 30 Sep 2016
Q2 2016 -204% +27% +12% 01 Apr 2016 30 Jun 2016
Q1 2016 -268% 01 Jan 2016 31 Mar 2016
Q4 2015 -249% 01 Oct 2015 31 Dec 2015
Q3 2015 -266% 01 Jul 2015 30 Sep 2015
Q2 2015 -231% 01 Apr 2015 30 Jun 2015

Hepion Pharmaceuticals, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -193% -42% -27% 01 Jan 2024 31 Dec 2024
2023 -152% -97% -178% 01 Jan 2023 31 Dec 2023
2022 -55% -26% -91% 01 Jan 2022 31 Dec 2022
2021 -29% +41% +59% 01 Jan 2021 31 Dec 2021
2020 -70% -31% -81% 01 Jan 2020 31 Dec 2020
2019 -39% +56% +59% 01 Jan 2019 31 Dec 2019
2018 -95% +14% +13% 01 Jan 2018 31 Dec 2018
2017 -108% +96% +47% 01 Jul 2016 30 Jun 2017
2016 -204% +27% +12% 01 Jul 2015 30 Jun 2016
2015 -231% +216% +48% 01 Jul 2014 30 Jun 2015
2014 -447% 01 Jul 2013 30 Jun 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.